TET Systems

The tetracycline inducible gene expression technology (Tet Technology) is one of the most widely used methods in basic and applied research as it allows tight and, most importantly, reversible control of gene expression in eukaryotic cells. It has been successfully applied in vitro and in vivo from early discovery to gene therapy applications. The broad applicability of the technology is highlighted by more than 20.000 scientific publications. 

TET Systems owns the entire patent portfolio and is the one stop-shop to obtain licenses required to access and use the Tet Technology depending on any organization’s specific needs.